

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.98779803 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.57187082 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.57187082 |
| 4 | negative thymic T cell selection (GO:0045060) | 5.51192233 |
| 5 | negative T cell selection (GO:0043383) | 5.46651510 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.36322149 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.26460761 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.18492524 |
| 9 | NIK/NF-kappaB signaling (GO:0038061) | 5.01761716 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.97623999 |
| 11 | positive thymic T cell selection (GO:0045059) | 4.84920228 |
| 12 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.82805696 |
| 13 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.82128992 |
| 14 | cellular response to interleukin-15 (GO:0071350) | 4.74964946 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.72314050 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.72314050 |
| 17 | tolerance induction (GO:0002507) | 4.63831824 |
| 18 | response to interleukin-15 (GO:0070672) | 4.62231439 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 4.59116762 |
| 20 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 4.57733623 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.56532062 |
| 22 | regulation of T cell tolerance induction (GO:0002664) | 4.52714129 |
| 23 | interferon-gamma production (GO:0032609) | 4.47414377 |
| 24 | thymic T cell selection (GO:0045061) | 4.43009619 |
| 25 | regulation of hypersensitivity (GO:0002883) | 4.33679033 |
| 26 | response to peptidoglycan (GO:0032494) | 4.28834536 |
| 27 | B cell mediated immunity (GO:0019724) | 4.22767942 |
| 28 | myeloid dendritic cell activation (GO:0001773) | 4.21123223 |
| 29 | myeloid dendritic cell differentiation (GO:0043011) | 4.17513967 |
| 30 | positive T cell selection (GO:0043368) | 4.12735771 |
| 31 | T cell selection (GO:0045058) | 4.09750304 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 4.01829408 |
| 33 | T cell migration (GO:0072678) | 4.00955025 |
| 34 | B cell receptor signaling pathway (GO:0050853) | 3.89008593 |
| 35 | regulation of B cell differentiation (GO:0045577) | 3.78565133 |
| 36 | positive regulation of mast cell activation (GO:0033005) | 3.78534168 |
| 37 | positive regulation of interleukin-2 production (GO:0032743) | 3.78058601 |
| 38 | response to muramyl dipeptide (GO:0032495) | 3.76659079 |
| 39 | neutrophil activation involved in immune response (GO:0002283) | 3.69946563 |
| 40 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.67402731 |
| 41 | positive regulation of mast cell degranulation (GO:0043306) | 3.67402731 |
| 42 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.65050005 |
| 43 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.64129606 |
| 44 | positive regulation of antigen processing and presentation (GO:0002579) | 3.63914323 |
| 45 | positive regulation of B cell differentiation (GO:0045579) | 3.63830526 |
| 46 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.59286623 |
| 47 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.55008851 |
| 48 | regulation of tolerance induction (GO:0002643) | 3.53891295 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.53587839 |
| 50 | T cell costimulation (GO:0031295) | 3.52095620 |
| 51 | regulation of chronic inflammatory response (GO:0002676) | 3.51271725 |
| 52 | leukocyte aggregation (GO:0070486) | 3.49205989 |
| 53 | lymphocyte costimulation (GO:0031294) | 3.47458453 |
| 54 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.45875486 |
| 55 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.40502610 |
| 56 | cellular response to interferon-gamma (GO:0071346) | 3.40434036 |
| 57 | T-helper cell differentiation (GO:0042093) | 3.40042385 |
| 58 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.40042385 |
| 59 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.36784019 |
| 60 | neutrophil activation (GO:0042119) | 3.36087345 |
| 61 | positive regulation of B cell mediated immunity (GO:0002714) | 3.35455241 |
| 62 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.35455241 |
| 63 | T cell receptor signaling pathway (GO:0050852) | 3.35234606 |
| 64 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.33781469 |
| 65 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29617106 |
| 66 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.28787076 |
| 67 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.28224888 |
| 68 | dendritic cell differentiation (GO:0097028) | 3.27546973 |
| 69 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.27279907 |
| 70 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.27279907 |
| 71 | germinal center formation (GO:0002467) | 3.26490418 |
| 72 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.26375827 |
| 73 | regulation of mast cell activation (GO:0033003) | 3.25240673 |
| 74 | immunoglobulin mediated immune response (GO:0016064) | 3.22990905 |
| 75 | defense response to protozoan (GO:0042832) | 3.22487135 |
| 76 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.18521403 |
| 77 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.18521403 |
| 78 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.18345708 |
| 79 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.16602935 |
| 80 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.16558158 |
| 81 | positive regulation of interleukin-12 production (GO:0032735) | 3.16364391 |
| 82 | regulation of antigen processing and presentation (GO:0002577) | 3.16197125 |
| 83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.15907261 |
| 84 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.14328290 |
| 85 | positive regulation of isotype switching (GO:0045830) | 3.13952926 |
| 86 | granulocyte activation (GO:0036230) | 3.11132105 |
| 87 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.10677425 |
| 88 | regulation of germinal center formation (GO:0002634) | 3.09792947 |
| 89 | regulation of response to interferon-gamma (GO:0060330) | 3.09721947 |
| 90 | response to interferon-gamma (GO:0034341) | 3.07929273 |
| 91 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.07888741 |
| 92 | detection of other organism (GO:0098543) | 3.07801557 |
| 93 | regulation of mast cell degranulation (GO:0043304) | 3.07636301 |
| 94 | response to protozoan (GO:0001562) | 3.06450484 |
| 95 | detection of bacterium (GO:0016045) | 3.06332935 |
| 96 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 3.06073995 |
| 97 | mast cell activation (GO:0045576) | 3.06041329 |
| 98 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.05970337 |
| 99 | production of molecular mediator of immune response (GO:0002440) | 3.05767377 |
| 100 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.05306926 |
| 101 | positive regulation of interferon-alpha production (GO:0032727) | 3.03780051 |
| 102 | negative regulation of bone resorption (GO:0045779) | 3.03561385 |
| 103 | regulation of interferon-alpha production (GO:0032647) | 3.03539167 |
| 104 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.03270273 |
| 105 | T cell differentiation involved in immune response (GO:0002292) | 3.02663014 |
| 106 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.02663014 |
| 107 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.02663014 |
| 108 | microglial cell activation (GO:0001774) | 3.02171635 |
| 109 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.01424406 |
| 110 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.01424406 |
| 111 | modulation by symbiont of host immune response (GO:0052553) | 3.01424406 |
| 112 | positive regulation by symbiont of host defense response (GO:0052509) | 3.01424406 |
| 113 | modulation by symbiont of host defense response (GO:0052031) | 3.01424406 |
| 114 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.01424406 |
| 115 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.01409568 |
| 116 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.01185400 |
| 117 | * mature B cell differentiation (GO:0002335) | 3.01004844 |
| 118 | negative regulation of granulocyte differentiation (GO:0030853) | 2.97773801 |
| 119 | response to type I interferon (GO:0034340) | 2.97324876 |
| 120 | macrophage activation involved in immune response (GO:0002281) | 2.96873607 |
| 121 | type I interferon signaling pathway (GO:0060337) | 2.96848821 |
| 122 | cellular response to type I interferon (GO:0071357) | 2.96848821 |
| 123 | regulation of interleukin-12 production (GO:0032655) | 2.94572104 |
| 124 | cellular response to zinc ion (GO:0071294) | 2.94566835 |
| 125 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.93927484 |
| 126 | positive regulation of interferon-gamma production (GO:0032729) | 2.91599788 |
| 127 | regulation of regulatory T cell differentiation (GO:0045589) | 2.90676662 |
| 128 | natural killer cell activation (GO:0030101) | 2.90573008 |
| 129 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.90143611 |
| 130 | T cell activation involved in immune response (GO:0002286) | 2.89993361 |
| 131 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.88843932 |
| 132 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87382044 |
| 133 | positive regulation of humoral immune response (GO:0002922) | 2.86025044 |
| 134 | myeloid cell activation involved in immune response (GO:0002275) | 2.85686438 |
| 135 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.84613184 |
| 136 | regulation of chemokine biosynthetic process (GO:0045073) | 2.84041779 |
| 137 | positive regulation of type 2 immune response (GO:0002830) | 2.81890379 |
| 138 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.81004651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.35234020 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.81501001 |
| 3 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.50039636 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.60443969 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.53113282 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.10270606 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.04103498 |
| 8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.63875223 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.48395791 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.43492454 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.39071493 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.32040594 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.26284715 |
| 14 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.21853509 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.13730062 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.07733468 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.05125198 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88524520 |
| 19 | * MYB_26560356_Chip-Seq_TH2_Human | 2.87675324 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.82489920 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.66608730 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.63677309 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.61302810 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.49726459 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.45593320 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.43910406 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37843792 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.25160732 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.21745537 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11677334 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06444320 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03036872 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01020842 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.98797348 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.97064886 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.92888426 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.91868839 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89672426 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87378561 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84976423 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83411778 |
| 42 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.76321446 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.70587425 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68494906 |
| 45 | * MAF_26560356_Chip-Seq_TH2_Human | 1.61868445 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.60025588 |
| 47 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.59962371 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56607638 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54008225 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52013950 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50538813 |
| 52 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46408261 |
| 53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40012725 |
| 54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39828537 |
| 55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33673539 |
| 56 | GATA3_26560356_Chip-Seq_TH2_Human | 1.32146767 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31600529 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26591202 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26027196 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25960943 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24647398 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23078907 |
| 63 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22749054 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21149069 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19105063 |
| 66 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18973666 |
| 67 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11411910 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11265483 |
| 69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.10781306 |
| 70 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09698009 |
| 71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08680092 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06045985 |
| 73 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.05800101 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04937833 |
| 75 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.03560048 |
| 76 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00595091 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00211670 |
| 78 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99723336 |
| 79 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96505902 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92465563 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89092930 |
| 82 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.88697371 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88608483 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88426542 |
| 85 | GATA3_26560356_Chip-Seq_TH1_Human | 0.86780298 |
| 86 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85130860 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84256162 |
| 88 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83830899 |
| 89 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.81197113 |
| 90 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78630713 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77742257 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77366931 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77082583 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.76063899 |
| 95 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.75314044 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.73908880 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.73395462 |
| 98 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.73391307 |
| 99 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.72901225 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.72738879 |
| 101 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72596800 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72116829 |
| 103 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.72074627 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.71062119 |
| 105 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70529157 |
| 106 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.70091876 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69523202 |
| 108 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69230387 |
| 109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68709973 |
| 110 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.67004161 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.66306464 |
| 112 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.63419461 |
| 113 | P300_27268052_Chip-Seq_Bcells_Human | 0.62557807 |
| 114 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.61578097 |
| 115 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.61355909 |
| 116 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.60739747 |
| 117 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.60167114 |
| 118 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.60010388 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.59888209 |
| 120 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.59205759 |
| 121 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.57253325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.69715955 |
| 2 | MP0005671_abnormal_response_to | 4.20673361 |
| 3 | MP0000685_abnormal_immune_system | 3.67249915 |
| 4 | MP0001790_abnormal_immune_system | 3.45307624 |
| 5 | MP0005387_immune_system_phenotype | 3.45307624 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.44953166 |
| 7 | * MP0001800_abnormal_humoral_immune | 3.44543170 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.30460432 |
| 9 | * MP0002452_abnormal_antigen_presenting | 3.02363095 |
| 10 | MP0004510_myositis | 2.98500326 |
| 11 | * MP0002723_abnormal_immune_serum | 2.96864067 |
| 12 | MP0003436_decreased_susceptibility_to | 2.86325382 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.86171324 |
| 14 | * MP0002420_abnormal_adaptive_immunity | 2.81228599 |
| 15 | * MP0001819_abnormal_immune_cell | 2.79708759 |
| 16 | MP0009785_altered_susceptibility_to | 2.70176658 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.68285954 |
| 18 | MP0002419_abnormal_innate_immunity | 2.60320532 |
| 19 | MP0006082_CNS_inflammation | 2.54102513 |
| 20 | MP0005025_abnormal_response_to | 2.52974486 |
| 21 | MP0002405_respiratory_system_inflammati | 2.42150083 |
| 22 | * MP0002398_abnormal_bone_marrow | 2.39899228 |
| 23 | MP0003303_peritoneal_inflammation | 2.37651436 |
| 24 | * MP0000716_abnormal_immune_system | 2.30284859 |
| 25 | MP0001853_heart_inflammation | 2.19989352 |
| 26 | MP0001873_stomach_inflammation | 2.17222393 |
| 27 | MP0002006_tumorigenesis | 2.07323695 |
| 28 | MP0003724_increased_susceptibility_to | 2.03846931 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.01968165 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 2.00859533 |
| 31 | MP0005310_abnormal_salivary_gland | 1.98454596 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.96559420 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.92635263 |
| 34 | MP0002722_abnormal_immune_system | 1.91843204 |
| 35 | MP0004947_skin_inflammation | 1.87502413 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.86842128 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.84991525 |
| 38 | * MP0002429_abnormal_blood_cell | 1.84401799 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.81497442 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.74922902 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.67747900 |
| 42 | MP0002933_joint_inflammation | 1.61972838 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.58749800 |
| 44 | MP0002254_reproductive_system_inflammat | 1.55793037 |
| 45 | MP0002009_preneoplasia | 1.55488788 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.50857485 |
| 47 | MP0003866_abnormal_defecation | 1.46202294 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.40499259 |
| 49 | MP0008469_abnormal_protein_level | 1.30422008 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.28795641 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.25476790 |
| 52 | MP0003448_altered_tumor_morphology | 1.24669560 |
| 53 | MP0000858_altered_metastatic_potential | 1.22113712 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.16141674 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.11763506 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.11054230 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.08386285 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.06062420 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.02849289 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.00259616 |
| 61 | MP0009764_decreased_sensitivity_to | 0.98300696 |
| 62 | MP0001851_eye_inflammation | 0.96892357 |
| 63 | MP0001501_abnormal_sleep_pattern | 0.95786496 |
| 64 | MP0001348_abnormal_lacrimal_gland | 0.94431664 |
| 65 | MP0008004_abnormal_stomach_pH | 0.92205129 |
| 66 | MP0000490_abnormal_crypts_of | 0.90895797 |
| 67 | MP0000343_altered_response_to | 0.89690096 |
| 68 | MP0001542_abnormal_bone_strength | 0.89517425 |
| 69 | MP0002139_abnormal_hepatobiliary_system | 0.89242709 |
| 70 | MP0001545_abnormal_hematopoietic_system | 0.86727146 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 0.86727146 |
| 72 | MP0008057_abnormal_DNA_replication | 0.85868787 |
| 73 | MP0003045_fibrosis | 0.85182441 |
| 74 | MP0003646_muscle_fatigue | 0.82050568 |
| 75 | MP0000249_abnormal_blood_vessel | 0.81133497 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 0.81023914 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.78882004 |
| 78 | MP0009840_abnormal_foam_cell | 0.78781347 |
| 79 | MP0002163_abnormal_gland_morphology | 0.78092575 |
| 80 | MP0008007_abnormal_cellular_replicative | 0.77771296 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 0.75647445 |
| 82 | MP0005076_abnormal_cell_differentiation | 0.75616617 |
| 83 | MP0005165_increased_susceptibility_to | 0.75519162 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.72766157 |
| 85 | MP0000015_abnormal_ear_pigmentation | 0.72284728 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.71934919 |
| 87 | MP0004381_abnormal_hair_follicle | 0.70619223 |
| 88 | MP0003828_pulmonary_edema | 0.70308061 |
| 89 | MP0006054_spinal_hemorrhage | 0.69509490 |
| 90 | MP0003091_abnormal_cell_migration | 0.69426173 |
| 91 | MP0009763_increased_sensitivity_to | 0.68866867 |
| 92 | MP0003795_abnormal_bone_structure | 0.67543502 |
| 93 | MP0000604_amyloidosis | 0.67246673 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 0.66381034 |
| 95 | MP0005390_skeleton_phenotype | 0.63607832 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.63578291 |
| 97 | MP0003075_altered_response_to | 0.63404282 |
| 98 | MP0005451_abnormal_body_composition | 0.61394165 |
| 99 | MP0005164_abnormal_response_to | 0.60146546 |
| 100 | MP0009278_abnormal_bone_marrow | 0.59738177 |
| 101 | MP0005166_decreased_susceptibility_to | 0.59195145 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.57513904 |
| 103 | MP0002928_abnormal_bile_duct | 0.56680359 |
| 104 | MP0003690_abnormal_glial_cell | 0.55651563 |
| 105 | MP0001243_abnormal_dermal_layer | 0.55534065 |
| 106 | MP0001919_abnormal_reproductive_system | 0.55459278 |
| 107 | MP0004883_abnormal_blood_vessel | 0.55426757 |
| 108 | MP0008875_abnormal_xenobiotic_pharmacok | 0.54122309 |
| 109 | MP0001663_abnormal_digestive_system | 0.52745363 |
| 110 | MP0000609_abnormal_liver_physiology | 0.52313256 |
| 111 | MP0005647_abnormal_sex_gland | 0.51205167 |
| 112 | MP0005535_abnormal_body_temperature | 0.51020611 |
| 113 | MP0001765_abnormal_ion_homeostasis | 0.50247591 |
| 114 | MP0000516_abnormal_urinary_system | 0.50120991 |
| 115 | MP0000371_diluted_coat_color | 0.48855375 |
| 116 | MP0002095_abnormal_skin_pigmentation | 0.48171098 |
| 117 | MP0001881_abnormal_mammary_gland | 0.46374269 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.46033313 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.45713813 |
| 120 | MP0003279_aneurysm | 0.45441974 |
| 121 | MP0008873_increased_physiological_sensi | 0.45137766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.04029021 |
| 2 | Myositis (HP:0100614) | 4.99222492 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.86568693 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 4.86015296 |
| 5 | Optic neuritis (HP:0100653) | 4.86015296 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.65279888 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.52762340 |
| 8 | Abnormality of T cell number (HP:0011839) | 4.50253988 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.49272510 |
| 10 | T lymphocytopenia (HP:0005403) | 4.43434509 |
| 11 | Orchitis (HP:0100796) | 4.40421219 |
| 12 | Stomatitis (HP:0010280) | 4.38839072 |
| 13 | Recurrent viral infections (HP:0004429) | 4.26855257 |
| 14 | IgM deficiency (HP:0002850) | 4.06912274 |
| 15 | Agammaglobulinemia (HP:0004432) | 4.00619124 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.94405395 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.94405395 |
| 18 | Severe combined immunodeficiency (HP:0004430) | 3.93691693 |
| 19 | Pulmonary infiltrates (HP:0002113) | 3.93634140 |
| 20 | Recurrent bronchitis (HP:0002837) | 3.93144440 |
| 21 | Thyroiditis (HP:0100646) | 3.88334258 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.84382479 |
| 23 | Panhypogammaglobulinemia (HP:0003139) | 3.81330245 |
| 24 | Chronic otitis media (HP:0000389) | 3.75844464 |
| 25 | Vasculitis (HP:0002633) | 3.70624700 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.66235988 |
| 27 | Combined immunodeficiency (HP:0005387) | 3.60842235 |
| 28 | Chronic diarrhea (HP:0002028) | 3.55603110 |
| 29 | Recurrent skin infections (HP:0001581) | 3.55428962 |
| 30 | Abnormality of T cells (HP:0002843) | 3.54971432 |
| 31 | Meningitis (HP:0001287) | 3.47933398 |
| 32 | Abnormality of eosinophils (HP:0001879) | 3.42395939 |
| 33 | Colitis (HP:0002583) | 3.35979863 |
| 34 | Systemic lupus erythematosus (HP:0002725) | 3.35117278 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 3.31358073 |
| 36 | IgG deficiency (HP:0004315) | 3.30523144 |
| 37 | Inflammation of the large intestine (HP:0002037) | 3.26502693 |
| 38 | Leukocytosis (HP:0001974) | 3.26457761 |
| 39 | Arterial thrombosis (HP:0004420) | 3.24007054 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 3.15508809 |
| 41 | Obstructive lung disease (HP:0006536) | 3.15508809 |
| 42 | Eosinophilia (HP:0001880) | 3.14055536 |
| 43 | Spontaneous hematomas (HP:0007420) | 3.08918752 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 3.05790376 |
| 45 | Increased IgM level (HP:0003496) | 3.04452047 |
| 46 | Keratoconjunctivitis (HP:0001096) | 3.04132260 |
| 47 | Hemoptysis (HP:0002105) | 3.02027580 |
| 48 | Encephalitis (HP:0002383) | 2.93883298 |
| 49 | Gastrointestinal stroma tumor (HP:0100723) | 2.88218579 |
| 50 | Nasal polyposis (HP:0100582) | 2.85904897 |
| 51 | Lymphopenia (HP:0001888) | 2.84906347 |
| 52 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.79750964 |
| 53 | Recurrent sinusitis (HP:0011108) | 2.79738562 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.78189901 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.77994526 |
| 56 | Gastrointestinal infarctions (HP:0005244) | 2.75962728 |
| 57 | Amyloidosis (HP:0011034) | 2.74819368 |
| 58 | Granulocytopenia (HP:0001913) | 2.74717470 |
| 59 | B lymphocytopenia (HP:0010976) | 2.73941239 |
| 60 | Abnormality of B cell number (HP:0010975) | 2.73941239 |
| 61 | IgA deficiency (HP:0002720) | 2.73396960 |
| 62 | Pustule (HP:0200039) | 2.72626813 |
| 63 | Polyneuropathy (HP:0001271) | 2.68263774 |
| 64 | Thrombocytosis (HP:0001894) | 2.68216080 |
| 65 | Urticaria (HP:0001025) | 2.67818146 |
| 66 | Gingivitis (HP:0000230) | 2.67734759 |
| 67 | Abnormality of the pleura (HP:0002103) | 2.64855280 |
| 68 | Abnormality of the prostate (HP:0008775) | 2.63048509 |
| 69 | Cellulitis (HP:0100658) | 2.61166008 |
| 70 | Increased IgE level (HP:0003212) | 2.55244125 |
| 71 | Glomerulonephritis (HP:0000099) | 2.53595708 |
| 72 | Abnormality of macrophages (HP:0004311) | 2.52379856 |
| 73 | Abnormality of the nasal mucosa (HP:0000433) | 2.49038143 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46712603 |
| 75 | Abnormality of the fingertips (HP:0001211) | 2.45559933 |
| 76 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.45334606 |
| 77 | Osteomyelitis (HP:0002754) | 2.44495890 |
| 78 | Increased density of long bones (HP:0006392) | 2.44423007 |
| 79 | Periodontitis (HP:0000704) | 2.43784911 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 2.40194916 |
| 81 | Prostate neoplasm (HP:0100787) | 2.38818685 |
| 82 | Alveolar cell carcinoma (HP:0006519) | 2.37993559 |
| 83 | Chest pain (HP:0100749) | 2.36369013 |
| 84 | Increased serum ferritin (HP:0003281) | 2.35302286 |
| 85 | Pulmonary fibrosis (HP:0002206) | 2.33425737 |
| 86 | Petechiae (HP:0000967) | 2.33384887 |
| 87 | Anorexia (HP:0002039) | 2.32668468 |
| 88 | Glomerulopathy (HP:0100820) | 2.32343420 |
| 89 | Increased cerebral lipofuscin (HP:0011813) | 2.32087544 |
| 90 | Joint swelling (HP:0001386) | 2.31448050 |
| 91 | Pulmonary embolism (HP:0002204) | 2.31389625 |
| 92 | Interstitial pulmonary disease (HP:0006530) | 2.30449276 |
| 93 | Persistence of primary teeth (HP:0006335) | 2.29788915 |
| 94 | Vacuolated lymphocytes (HP:0001922) | 2.26624066 |
| 95 | Hematochezia (HP:0002573) | 2.24114137 |
| 96 | Emphysema (HP:0002097) | 2.23511402 |
| 97 | Fatigue (HP:0012378) | 2.23448500 |
| 98 | Lymphoma (HP:0002665) | 2.23255784 |
| 99 | Hypoplasia of the thymus (HP:0000778) | 2.22310794 |
| 100 | Restrictive lung disease (HP:0002091) | 2.21711935 |
| 101 | Amaurosis fugax (HP:0100576) | 2.21577331 |
| 102 | Gingival bleeding (HP:0000225) | 2.20208137 |
| 103 | Stomach cancer (HP:0012126) | 2.19062912 |
| 104 | Epistaxis (HP:0000421) | 2.18758977 |
| 105 | Myocardial infarction (HP:0001658) | 2.18493499 |
| 106 | Vertigo (HP:0002321) | 2.17311958 |
| 107 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.17182950 |
| 108 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.17182950 |
| 109 | Abnormality of glycolipid metabolism (HP:0010969) | 2.17182950 |
| 110 | Arthralgia (HP:0002829) | 2.16770793 |
| 111 | Loss of speech (HP:0002371) | 2.16010675 |
| 112 | Gangrene (HP:0100758) | 2.15368654 |
| 113 | Verrucae (HP:0200043) | 2.14908693 |
| 114 | Papilloma (HP:0012740) | 2.14908693 |
| 115 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.14365624 |
| 116 | Basal ganglia calcification (HP:0002135) | 2.13830109 |
| 117 | Dysostosis multiplex (HP:0000943) | 2.12690864 |
| 118 | Autoimmune hemolytic anemia (HP:0001890) | 2.12097047 |
| 119 | Disinhibition (HP:0000734) | 2.11814542 |
| 120 | Keratitis (HP:0000491) | 2.06504062 |
| 121 | Thrombophlebitis (HP:0004418) | 2.03242475 |
| 122 | Abnormality of iron homeostasis (HP:0011031) | 2.02166154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.96239873 |
| 2 | MAP4K1 | 4.75032574 |
| 3 | MAP3K14 | 4.20316511 |
| 4 | TYK2 | 3.01330156 |
| 5 | TGFBR2 | 2.74075616 |
| 6 | BLK | 2.62674449 |
| 7 | JAK3 | 2.56196334 |
| 8 | IKBKE | 2.53306446 |
| 9 | TBK1 | 2.52797777 |
| 10 | IKBKB | 2.51900044 |
| 11 | ITK | 2.49236751 |
| 12 | IRAK3 | 2.48543862 |
| 13 | CDK19 | 2.41870451 |
| 14 | JAK1 | 2.41477925 |
| 15 | IRAK4 | 2.37276460 |
| 16 | MAP3K13 | 2.29285406 |
| 17 | ZAP70 | 2.14103375 |
| 18 | MAP3K12 | 2.05473244 |
| 19 | STK10 | 2.03693215 |
| 20 | TEC | 1.89176619 |
| 21 | CHUK | 1.83366669 |
| 22 | TAOK3 | 1.81008537 |
| 23 | CSF1R | 1.74148573 |
| 24 | BTK | 1.73598089 |
| 25 | GRK6 | 1.69554430 |
| 26 | SYK | 1.66542591 |
| 27 | KIT | 1.65395009 |
| 28 | FGFR4 | 1.57037073 |
| 29 | LCK | 1.56423324 |
| 30 | TLK1 | 1.54404754 |
| 31 | MAP2K2 | 1.52116024 |
| 32 | CSK | 1.44699989 |
| 33 | HCK | 1.40179336 |
| 34 | EPHB1 | 1.39128804 |
| 35 | NLK | 1.37349411 |
| 36 | FGFR3 | 1.32095926 |
| 37 | RIPK4 | 1.25168896 |
| 38 | TRPM7 | 1.22979779 |
| 39 | MST4 | 1.18616732 |
| 40 | PIM1 | 1.15347779 |
| 41 | TSSK6 | 1.14877994 |
| 42 | TAOK2 | 1.11050313 |
| 43 | LYN | 1.09163687 |
| 44 | CLK1 | 1.07827665 |
| 45 | MAP3K10 | 1.06294688 |
| 46 | EPHA3 | 1.05869716 |
| 47 | MAPK15 | 1.01982506 |
| 48 | ERBB3 | 0.99015705 |
| 49 | GRK7 | 0.98803351 |
| 50 | JAK2 | 0.96735897 |
| 51 | RPS6KA4 | 0.94779438 |
| 52 | NEK9 | 0.94267676 |
| 53 | PRKCQ | 0.88007787 |
| 54 | SIK2 | 0.87609454 |
| 55 | BCKDK | 0.86584976 |
| 56 | PIK3CG | 0.86010911 |
| 57 | FES | 0.85345315 |
| 58 | LRRK2 | 0.77123628 |
| 59 | CAMKK2 | 0.76212220 |
| 60 | MARK3 | 0.75804549 |
| 61 | MYLK | 0.72355086 |
| 62 | IRAK1 | 0.71339671 |
| 63 | MAP3K3 | 0.68882137 |
| 64 | ARAF | 0.67411299 |
| 65 | SIK3 | 0.67037582 |
| 66 | PIM2 | 0.64742517 |
| 67 | MAP4K2 | 0.64583648 |
| 68 | PKN1 | 0.62618919 |
| 69 | CAMKK1 | 0.59310513 |
| 70 | OXSR1 | 0.58768223 |
| 71 | MAPKAPK2 | 0.58662785 |
| 72 | CDK12 | 0.57549617 |
| 73 | PASK | 0.55754810 |
| 74 | MAPK12 | 0.55620895 |
| 75 | MAP2K3 | 0.54472225 |
| 76 | PRPF4B | 0.54128648 |
| 77 | TESK2 | 0.49969359 |
| 78 | RPS6KA5 | 0.49423389 |
| 79 | EIF2AK2 | 0.48624670 |
| 80 | EEF2K | 0.48595551 |
| 81 | MAP3K1 | 0.47206621 |
| 82 | KDR | 0.46983884 |
| 83 | CDK9 | 0.46557681 |
| 84 | MELK | 0.45660683 |
| 85 | BMPR2 | 0.45358194 |
| 86 | HIPK2 | 0.45333889 |
| 87 | MAPK7 | 0.45212839 |
| 88 | FGR | 0.43611733 |
| 89 | IGF1R | 0.43250467 |
| 90 | TGFBR1 | 0.43024181 |
| 91 | INSR | 0.41652637 |
| 92 | PRKCD | 0.39892215 |
| 93 | PDK1 | 0.38158081 |
| 94 | RPS6KA6 | 0.37342703 |
| 95 | MATK | 0.36668021 |
| 96 | MAP3K11 | 0.36312737 |
| 97 | RPS6KL1 | 0.35463806 |
| 98 | RPS6KC1 | 0.35463806 |
| 99 | PDGFRB | 0.35364507 |
| 100 | ERN1 | 0.34884601 |
| 101 | CDK6 | 0.34649287 |
| 102 | ABL1 | 0.34459845 |
| 103 | PTK6 | 0.34254217 |
| 104 | MAPK11 | 0.33800593 |
| 105 | FLT3 | 0.32982695 |
| 106 | NUAK1 | 0.32593919 |
| 107 | DAPK3 | 0.32292374 |
| 108 | TNK2 | 0.30681032 |
| 109 | STK24 | 0.30550428 |
| 110 | EGFR | 0.30174236 |
| 111 | CDK4 | 0.30130980 |
| 112 | FYN | 0.29562761 |
| 113 | MAP3K5 | 0.29441502 |
| 114 | NME2 | 0.29142897 |
| 115 | EIF2AK3 | 0.27787528 |
| 116 | VRK1 | 0.26201680 |
| 117 | MOS | 0.26165716 |
| 118 | IRAK2 | 0.25315100 |
| 119 | GSK3A | 0.25060735 |
| 120 | ADRBK2 | 0.24733848 |
| 121 | MAP2K6 | 0.23514183 |
| 122 | ABL2 | 0.22946587 |
| 123 | PRKAA2 | 0.22479676 |
| 124 | MAPK3 | 0.21717908 |
| 125 | STK4 | 0.21708462 |
| 126 | ILK | 0.20417337 |
| 127 | MAP3K7 | 0.19699464 |
| 128 | RPS6KA1 | 0.19046041 |
| 129 | BRD4 | 0.18768429 |
| 130 | MAPK4 | 0.18550776 |
| 131 | CAMK1D | 0.18202051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.86064256 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.19851904 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.00468459 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.91712416 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.81754975 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.80721279 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.65427623 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.61331571 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.58774353 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.58129822 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.53592879 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.48509904 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.24566535 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.12444006 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93994404 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.93174652 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.90610046 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.79545240 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.74330126 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.72213750 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.72118344 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.59746519 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58714709 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.56469381 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55203711 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54499959 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.47485336 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46518209 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.43735243 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42453460 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41724437 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.40132371 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.39162982 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.36634879 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.34623571 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.33941237 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.26596614 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.23461978 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.19753409 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.18801285 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16911841 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14246798 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10762919 |
| 44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09004416 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03388728 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.98671310 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97481369 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 0.96590155 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95012702 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94337921 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93946813 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93597386 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85431653 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85219975 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82901201 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.82196580 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.81553256 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74483370 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72230211 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68526809 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68061291 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67861809 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64260748 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60543584 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.59890052 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56679385 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56669753 |
| 68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51362794 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50515580 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48850604 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46435354 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45833423 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41488858 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.41387960 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39954394 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37994736 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37886898 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37484077 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37467156 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37385341 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36612294 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33644388 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33436257 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33388455 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32801554 |
| 86 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.31907029 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.31750792 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28709170 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27957866 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.26499065 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26437758 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25846300 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25072871 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24782457 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.23701336 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23534226 |
| 97 | Ribosome_Homo sapiens_hsa03010 | 0.23217923 |
| 98 | Pathways in cancer_Homo sapiens_hsa05200 | 0.22878723 |
| 99 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.22055650 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21766512 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21217997 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20800915 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.20756899 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18183542 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17496670 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.16304024 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.15940185 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | 0.15491238 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13919407 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.12358822 |
| 111 | Proteasome_Homo sapiens_hsa03050 | 0.12194998 |
| 112 | Base excision repair_Homo sapiens_hsa03410 | 0.10904389 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.09658514 |
| 114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.08376193 |
| 115 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06083596 |
| 116 | Parkinsons disease_Homo sapiens_hsa05012 | 0.04650861 |
| 117 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.00456555 |
| 118 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | -0.0618826 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | -0.0546388 |
| 120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0484787 |
| 121 | RNA degradation_Homo sapiens_hsa03018 | -0.0259786 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0169212 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0119369 |
| 124 | Tryptophan metabolism_Homo sapiens_hsa00380 | -0.0115112 |
| 125 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0060761 |
| 126 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0005292 |

